SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056417
Filing Date
2021-11-12
Accepted
2021-11-12 06:36:01
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eldn-10q_20210930.htm   iXBRL 10-Q 2437526
2 EX-31.1 eldn-ex311_9.htm EX-31.1 11387
3 EX-31.2 eldn-ex312_7.htm EX-31.2 11434
4 EX-32.1 eldn-ex321_6.htm EX-32.1 7514
5 EX-32.2 eldn-ex322_8.htm EX-32.2 7805
  Complete submission text file 0001564590-21-056417.txt   6992757

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eldn-20210930.xsd EX-101.SCH 51367
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eldn-20210930_cal.xml EX-101.CAL 46106
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eldn-20210930_def.xml EX-101.DEF 166485
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eldn-20210930_lab.xml EX-101.LAB 356018
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eldn-20210930_pre.xml EX-101.PRE 274198
11 EXTRACTED XBRL INSTANCE DOCUMENT eldn-10q_20210930_htm.xml XML 1034355
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 211399329
SIC: 2834 Pharmaceutical Preparations